EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study

Cristina Pimenta iD, Claudio G Mann, Brenda Hoagland, Eduardo Carvalheira, Cristina Jalil, Marcos Benedetti, Nilo Fernandes, Carolina Coutinho, Emilia M Jalil, Mayara Secco Torres Silva, Roberta Trefiglio, Alessandro Farias und 9 weitere

Journal of the International AIDS Society · 2025-07 · 28 (S2)

DOI: 10.1002/jia2.26493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the International AIDS Society, online erschienen am 02.07.2025. Verfasst von Cristina Pimenta und 20 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Telemedicine, Anti-HIV Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitaid, World Health Organization, Ministry of Health of Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although the efficacy of long‐acting injectable cabotegravir (CAB‐LA) for pre‐exposure prophylaxis (PrEP) is well‐known from clinical trials, research is needed to guide effective strategies for its implementation. We describe a qualitative study to assess perceptions and preferences for PrEP choice and acceptability of an mHealth intervention within the ImPrEP CAB Brasil study.

Methods

ImPrEP CAB Brasil is an implementation study of same‐day delivery of CAB‐LA for young sexual and gender minorities (SGM; 18–30 years) in oral PrEP public health clinics in six Brazilian cities. At enrolment, participants received counselling on HIV prevention (SOC) or SOC+mHealth tool to choose between oral or injectable PrEP. The mHealth tool consisted of five videos describing HIV combined prevention including PrEP options. A subset of participants from each site were invited to participate in the qualitative study (October 2023−July 2024). Semi‐structured interviews were conducted, recorded and transcribed. Data were fed into ATLAS.ti.24 software. Conventional content analysis was used for coding categories based on an inductive reasoning process.

Results

We conducted 120 interviews (48 SOC and 72 SOC+mHealth; 107 CAB‐LA and 13 oral PrEP). Participants reported not knowing about CAB‐LA before enrolment; some recently heard from a partner or friend. Reasons for choosing CAB‐LA were perceived convenience, practicality, easier adherence to bimonthly injections and higher efficacy compared to oral PrEP. Reasons for not choosing CAB‐LA were fear of injections and pain. Reasons for choosing oral PrEP included perspective of less appointments, easiness of daily adherence, access in case of travel and the option to stop immediately if desired or needed. Reasons for not choosing oral PrEP included forgetfulness of daily intake, gastrointestinal side effects, fear of inadvertent exposure and judgement by family. Participants found the mHealth educational tool useful and adequate for PrEP education and decision‐making.

Conclusions

Perceptions for PrEP choice among SGM underscore the importance of providing comprehensive information and support towards decision‐making processes, so users can have an accurate understanding of each PrEP option, as well as their clinical and social benefits. The mHealth tool was perceived as highly desirable and useful for PrEP education, having the potential to be implemented in HIV prevention services. Clinical Trial Number NCT05515770

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsTelemedicineAnti-HIV AgentsSexual and Gender MinoritiesPatient PreferenceHumansAdultMaleFemaleYoung AdultBrazilAdolescentPatient Acceptance of Health CareQualitative ResearchAdministration, OralPyridonesDiketopiperazines

Stichwörter der Autor:innen

HIV preventionPrEPcabotegravirimplementationmHealthsexual and gender minorities

Substanzen

Anti-HIV AgentscabotegravirPyridonesDiketopiperazines

Autor:innen und Institutionen

  • Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
  • Centro Especializado em Diagnóstico, Assistência e Pesquisa -CEDAP, Salvador, Brazil.
  • Fundação de Medicina Tropical Heitor Vieira Dourado, Manaus, Brazil.
  • Centro de Referência e Treinamento em DST/Aids - CRT, São Paulo, Brazil.
  • Centro de Referência em DST/Aids, Campinas, Brazil.
  • Aconselhamento - CTA/Policlínica Centro, Florianópolis, Brazil.

ORCID-Profile: Cristina Pimenta, Beatriz Grinsztejn

Förderung

  • Unitaid
  • World Health Organization
  • Ministry of Health of Brazil
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • CNPq
  • FAPERJ

Zitieren

APA

Pimenta, C., Mann, C. G., Hoagland, B., Carvalheira, E., Jalil, C., Benedetti, M., Fernandes, N., Coutinho, C., Jalil, E. M., Secco Torres Silva, M., Trefiglio, R., Farias, A., Mourão, M. P. G., Madruga, J. V., de Lima, J. N., Zonta, R., O'Malley, G., Veloso, V. G., Grinsztejn, B., …, & ImPrEP CAB‐Brasil Study (2025). Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study. Journal of the International AIDS Society, 28(S2). https://doi.org/10.1002/jia2.26493

Vancouver

Pimenta C, Mann CG, Hoagland B, Carvalheira E, Jalil C, Benedetti M, et al. Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study. Journal of the International AIDS Society. 2025;28(S2). doi:10.1002/jia2.26493

BibTeX
@article{Pimenta2025,
  author = {Pimenta, Cristina and Mann, Claudio G and Hoagland, Brenda and Carvalheira, Eduardo and Jalil, Cristina and Benedetti, Marcos and Fernandes, Nilo and Coutinho, Carolina and Jalil, Emilia M and Secco Torres Silva, Mayara and Trefiglio, Roberta and Farias, Alessandro and Mourão, Maria Paula G and Madruga, José Valdez and de Lima, Josué N and Zonta, Ronaldo and O'Malley, Gabrielle and Veloso, Valdilea G and Grinsztejn, Beatriz and Torres, Thiago S and ImPrEP CAB‐Brasil Study, ImPrEP CAB‐Brasil Study},
  title = {Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  volume = {28},
  number = {S2},
  doi = {10.1002/jia2.26493}
}
Kostenlos starten →